Broadcom: The Market Is Overreacting Again, And Now There's A Path To $30 In EPS

Broadcom reported record Q3 results, with AI semiconductor revenue up 221% YoY and total revenue up 86% YoY, beating consensus. Management outlined “hard targets” of ~$115B AI revenue by 2027 and ~$230B by 2028, guiding to EPS above $30 by fiscal 2028 (with supply reportedly already secured). The analyst model aligns with guidance, projecting $30.89 EPS in 2028, and cites attractive valuation at ~11x 2028 EPS, supporting an overall bullish read-through for the stock.

Analysis

The important signal is not the beat; it is that management is effectively converting AI into a long-duration backlog story. That tends to compress the “AI uncertainty discount” applied to AVGO and, more importantly, shifts attention from near-term revenue surprises to multi-year capacity allocation, where the scarce assets are not just GPUs but advanced packaging, wafer starts, and design-in slots. If those supply commitments are real, the upstream beneficiaries are the foundry and equipment stack — especially TSM, AMAT, KLAC, and select OSAT/packaging names — because pricing power migrates to whoever controls bottlenecks.

Second-order, this is a relative headwind for pure-play AI accelerator exposure that depends on hyperscaler capex being infinite. Custom silicon is a substitution threat to NVDA at the margin over 6-18 months, but the more immediate loser is any AI supplier whose thesis depends on open-ended mix expansion rather than locked-in customer programs. The market may underappreciate that AVGO’s software and cash-return profile can make the stock trade less like a cyclical semiconductor name and more like an infrastructure compounder, which supports a higher durable multiple than peers.

The main risk is not execution on next quarter; it is digestion. In the next 1-3 months, any pause in hyperscaler capex or commentary about cloud ROI could force investors to mark down 2027-2028 ramps sharply. The thesis is falsified if upcoming customer budgets, gross margin, or backlog commentary imply that the secured supply is insufficient or that pricing is being traded away to win design slots.

Key Decisions for Investors

• Add AVGO on 3-5% pullbacks or after the first post-earnings consolidation day; treat it as a 12-18 month core hold while the market re-rates multi-year AI visibility. Falsify if management guides to slower-than-expected AI conversion or margin compression.
• Pair trade: long AVGO / short MRVL over the next 1-3 months. AVGO has better visibility, stronger cash return, and more balanced earnings quality; MRVL remains more dependent on incremental AI design wins and is more vulnerable if hyperscaler spending normalizes.
• Long TSM or AMAT on weakness as a second-order beneficiary trade over 6-12 months. If AVGO truly has supply secured, the upstream constraint set should keep foundry and equipment utilization tight longer than the market is pricing.
• If semiconductor beta is a concern, hedge AVGO with a partial short in SOXX instead of a single-name short. That isolates the idiosyncratic AVGO re-rating while reducing exposure to a broader AI hardware de-rating.